Daily Roundup

8CO.ASX BIO.ASX JLG.ASX ABV.ASX SOL.ASX

NSW Department of Education renews contract with Expense8

8common's wholly-owned subsidiary Expense8 has renewed its contract with the NSW Department of Education for a 2-year fixed term with two 1-year extension options, representing an estimated total contract value of $3.54 million including GST. This is the 2nd renewal since Expense8 went live with the Department in June 2015, bringing the total contract value to $8.27 million. Expense8 processes over 1 million transactions annually across 36,000 staff and 20,000 corporate cards, making the platform deeply embedded in the Department's daily financial operations.

Biome Secures New Zealand Pharmacy Deal

Biome Australia has secured a strategic partnership with Green Cross Health, New Zealand's largest pharmacy network, to launch its Activated Probiotics range across 328 stores from September 2025. Green Cross Health operates 40% of New Zealand's total prescription volume, serving 1.95 million loyalty program members. This expansion directly advances Biome's Vision 27 strategic framework, which targets at least $75 million in cumulative revenue over the next few years. Biome expects this relationship to generate meaningful revenue as it establishes market presence and leverages Green Cross Health's extensive consumer touchpoints and clinical credibility.

Johns Lyng Group Shareholders to vote on proposed Scheme

Johns Lyng Group Limited (JLG) has announced that its shareholders will vote on a proposed scheme of arrangement with Bidder, an entity owned by Pacific Equity Partners. Under the terms, general JLG shareholders will receive $4.00 cash per share, while relevant shareholders can elect to receive some or all of their consideration in the form of scrip. The Independent Directors unanimously recommend voting in favor of the scheme, in the absence of a superior proposal and subject to the Independent Expert's conclusion that the scheme is fair and reasonable.

Advanced Braking Technology Ltd Reports FY 2025 Results

Advanced Braking Technology Ltd (ABT) has reported a strong FY 2025 performance, with revenue increasing 36.3% year-on-year to $19.1 million and underlying net profit after tax growing 34.9% to $0.463 million. The company also strengthened its liquidity, with cash and cash equivalents rising 19.4% to $2.875 million. Looking ahead, ABT expects to deliver revenue growth of 25-30% and an underlying NPAT margin of 12-15% in FY 2026, driven by increasing global demand for its innovative braking solutions, strategic partnerships, and operational excellence.

Soul Patts-Brickworks Merger Update

Washington H. Soul Pattinson and Brickworks have provided an update on their proposed merger, with shareholders set to vote on the schemes on 10 September 2025. The Supreme Court of New South Wales will then hear the applications for scheme approval on 12 September 2025. Any shareholders wishing to oppose the schemes must file the necessary documents in advance of the Second Court Hearings.